Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inge Verbrugge

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2006
TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancyEsther H J Wissink, Inge Verbrugge, Stefan R Vink, et al.
Cancer Immunology Research|February 21, 2019
Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell ActivityPaula Kroon, Elselien Frijlink, Victoria Iglesias-Guimarais, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2016
Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanomaPaula Kroon, Jules Gadiot, Marlies Peeters, et al.
Scientific Reports|October 3, 2024
Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumabKim Thys, Matthew J Loza, Linghua Lynn, et al.
Cancer Research|May 10, 2012
Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodiesInge Verbrugge, Jim Hagekyriakou, Leslie L Sharp, et al.
Cancer Research|December 3, 2015
The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid LeukemiaAdele Baker, Gareth P Gregory, Inge Verbrugge, et al.
Radiation Research|June 25, 2014
The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signalingInge Verbrugge, Alessia Gasparini, Nicole M Haynes, et al.
Blood|January 14, 2014
Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitorsMichael Bots, Inge Verbrugge, Benjamin P Martin, et al.
Antiviral Therapy|January 24, 2023
Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participantsLiviawati S Wu, Yue Hu, Edward J Gane, et al.
Antiviral Therapy|May 18, 2023
A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adultsWim Pierson, Marianne Tuefferd, Florence Herschke, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2006
TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancyEsther H J Wissink, Inge Verbrugge, Stefan R Vink, et al.
Cancer Immunology Research|February 21, 2019
Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell ActivityPaula Kroon, Elselien Frijlink, Victoria Iglesias-Guimarais, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2016
Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanomaPaula Kroon, Jules Gadiot, Marlies Peeters, et al.
Scientific Reports|October 3, 2024
Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumabKim Thys, Matthew J Loza, Linghua Lynn, et al.
Cancer Research|May 10, 2012
Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodiesInge Verbrugge, Jim Hagekyriakou, Leslie L Sharp, et al.
Cancer Research|December 3, 2015
The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid LeukemiaAdele Baker, Gareth P Gregory, Inge Verbrugge, et al.
Radiation Research|June 25, 2014
The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signalingInge Verbrugge, Alessia Gasparini, Nicole M Haynes, et al.
Blood|January 14, 2014
Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitorsMichael Bots, Inge Verbrugge, Benjamin P Martin, et al.
Antiviral Therapy|January 24, 2023
Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participantsLiviawati S Wu, Yue Hu, Edward J Gane, et al.
Antiviral Therapy|May 18, 2023
A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adultsWim Pierson, Marianne Tuefferd, Florence Herschke, et al.
Pageof 3